Home › Funds › Affinity Asset Advisors, LLC › MLYS

Affinity Asset Advisors, LLC position in MLYS

MINERALYS THERAPEUTICS INC · Health Care

Affinity Asset Advisors, LLC reported holding 750,000 shares of MLYS (MINERALYS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$18.8M, representing 0.88% of its reported portfolio and ranking #30 among its reported holdings. Affinity Asset Advisors, LLC has disclosed MLYS holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)750.00K sh
Reported value held$18.85M
Portfolio Weight0.88%
First reportedQ1 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's MLYS position evolved

Affinity Asset Advisors, LLC first disclosed a stake in MLYS in Q1 2024 at 327,959 shares (US$4.2M). The position peaked in Q3 2025 at 750,000 shares, worth US$28.4M. Across 11 filings, Affinity Asset Advisors, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 750,000 shares valued at US$18.8M. Notable position changes include a 43% trim in Q1 2025 (shares fell 15% over the following quarter), a 350% increase in Q2 2025 (shares rose 180% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 327.96K $4.23M New
Q2 2024 327.96K $3.84M Hold
Q3 2024 350.00K $4.24M Add
Q4 2024 350.00K $4.31M Hold
Q1 2025 200.00K $3.18M Reduce
Q2 2025 900.00K $12.18M Add
Q3 2025 750.00K $28.44M Reduce
Q4 2025 730.00K $26.49M Reduce
Q1 2026 750.00K $20.32M Add
Q2 2026 750.00K $20.23M Hold
Q3 2026 750.00K $18.85M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MLYS and 13F data

MLYS (MINERALYS THERAPEUTICS INC) is a Health Care company. 50 other funds we track also report a position in MLYS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), Samsara BioCapital, LLC (US$158.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLYS

All MLYS fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held MLYS?

Affinity Asset Advisors, LLC has disclosed MLYS holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Affinity Asset Advisors, LLC's current position in MLYS?

As of Q3 2026, Affinity Asset Advisors, LLC holds 750.00K shares of MLYS (MINERALYS THERAPEUTICS INC), valued at $18.85M, representing 0.88% of its reported portfolio and ranking #30.

Has Affinity Asset Advisors, LLC been buying or selling MLYS?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC held unchanged its position in MLYS. The position peaked in Q3 2025 at 750.00K shares.

Which other funds hold MLYS?

Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, Samsara BioCapital, LLC, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.